Ventyx Biosciences, Inc. (VTYX)
13.88
0.00 (0.00%)
USD |
NASDAQ |
Jan 21, 10:55
Ventyx Biosciences Total Assets (Quarterly): 211.46M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 114.94B |
| Revolution Medicines, Inc. | 2.252B |
| BioAge Labs, Inc. | 305.09M |
| Vera Therapeutics, Inc. | 517.50M |
| Neumora Therapeutics, Inc. | 177.83M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.10M |
| Shareholders Equity (Quarterly) | 191.36M |
| Debt to Equity Ratio | 0.0524 |
| Current Ratio | 17.86 |
| Net Debt Paydown Yield | 0.11% |